Check out our COVID-19 dedicated page for tenders related to medical equipment needs.
The Conference on the Future of Europe is your chance to share your ideas and shape the future of Europe. Make your voice heard!
Sweden-Östersund: Research and experimental development services
Section I: Contracting authority
This PCP is carried out by Jämtlands Läns Landsting, lead procurer acting in the name and on behalf of the buyers group listed in I.1. The applicable national procurement law is Swedish law.
Section II: Object
Pre-commercial Procurement of innovative ICT-enabled integrated care solutions to advance multidisciplinary health and care for patients with chronic heart failure
This contract notice invites interested operators to submit tenders to a procurement.
The procurement aims to trigger new solutions to be developed and tested to advance multidisciplinary health and care for patients with chronic heart failure (CHF). The procurement should address the procurers' unmet needs relating to different aspects (building blocks) of continuous management and seamless transitions of care for CHF patients: a) early diagnosis and anticipatory care b) care and follow-up c) living with heart failure.
More information can be found on the INCAREHEART website: https://incareheart.eu/
Testing is expected to take place at the procurers' sites – in Regions Jämtland Härjedalen and Västerbotten (Sweden), Thessaloniki (Greece), Naples (Italy), Amadora (Portugal) and Istanbul (Turkey)
Procurement will take the form of pre-commercial procurement (PCP), where R&D service contracts will be awarded in parallel to different R&D providers in a phased approach. This will allow alternative, competing solutions to be compared. Each selected operator will receive a framework contract covering three R&D phases. The three phases are: Solution design, prototype development, original development and validation and testing of a limited volume of the first products or services. After each phase, interim evaluations are conducted to select the best of the competing solutions. The contractors with the best value for money will be offered a specific contract for the next phase. The selected operators will retain ownership of the intellectual property rights (IPRs) they generate during the PCP and will be able to use them to exploit the full market potential of the solutions developed.
This procurement is funded by the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No. 965134 - INCAREHEART (https://incareheart.eu/). The EU has awarded a grant for this procurement but is not participating as a contracting authority in the procurement.
Estimated total value: 4 650 000 € incl. VAT, if applicable.
INCAREHEART carried out a series of open market consultation (OMC) events in the period 10 June - 27 September 2021 to inform the specifications of the tender. All materials and recordings are available at https://incareheart.eu/#OMC. Participation in the OMC events is not a prerequisite for submitting a tender for this call.
Section III: Legal, economic, financial and technical information
Section IV: Procedure
Region Jämtland Härjedalen - R&D Department, ProjectCentre, Östersund
Section VI: Complementary information
The PCP procurement is exempted from the WTO Government Procurement Agreement (GPA), the EU public procurement directives and the national laws that implement them (because it concerns the procurement of R&D services where the benefits do not accrue exclusively to the contracting authority for its use in the conduct of its own affairs).